In addition, while biomarkers such as human epidermal growth factor receptor 2, microsatellite instability, and Epstein–Barr virus status are increasingly recognized for their relevance in GC biology and treatment, their prognostic significance in patients undergoing curative resection remains limited [56,57,58]. The gene discussed is ERBB2; the disease is gastric cancer.